Literature DB >> 12892689

Improved fertility following conservative surgical treatment of ectopic pregnancy.

Nannie Bangsgaard1, Claus Otto Lund, Bent Ottesen, Lisbeth Nilas.   

Abstract

OBJECTIVE: To evaluate fertility after salpingectomy or tubotomy for ectopic pregnancy.
DESIGN: Retrospective cohort study.
SETTING: Clinical University Center, Hvidovre Hospital, Copenhagen. POPULATION: Two hundred and seventy-six women undergoing salpingectomy or tubotomy for their first ectopic pregnancy between January 1992 and January 1999 and who actively attempted to conceive were followed for a minimum of 18 months.
METHODS: Retrospective cohort study combined with questionnaire to compare reproductive outcome following salpingectomy or tubotomy for ectopic pregnancy. Cumulative probabilities of pregnancy for each group were calculated by the Kaplan-Meier estimator and compared by Cox regression analysis to control for potential confounders. MAIN OUTCOME MEASURES: Intrauterine pregnancy rates and recurrence rates of ectopic pregnancy after surgery for ectopic pregnancy.
RESULTS: The cumulative intrauterine pregnancy rate was significantly higher after tubotomy (88%) than after salpingectomy (66%) (log rank P < 0.05) after correction for confounding factors. No difference was found in the recurrence rate of ectopic pregnancy between the treatments (16% vs 17%). In patients with contralateral tubal pathology, the chance of pregnancy was poor (hazard ratio 0.463) and the risk of recurrence was high (hazard ratio 2.25), assessed with Cox regression. The rate of persistent ectopic pregnancy was 8%.
CONCLUSION: Conservative surgery is superior to radical surgery at preserving fertility. Conservative surgery is not followed by an increased risk of repeat ectopic pregnancy, but by the risk of persistent ectopic pregnancy, which should be taken into account when deciding on the operative procedure. Management in case of contralateral tubal pathology is disputed and should ideally be addressed in a randomised clinical trial.

Entities:  

Mesh:

Year:  2003        PMID: 12892689

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  20 in total

Review 1.  Tubal ectopic pregnancy.

Authors:  Rajesh Varma; Janesh Gupta
Journal:  BMJ Clin Evid       Date:  2012-02-10

Review 2.  Tubal ectopic pregnancy.

Authors:  Rajesh Varma; Janesh Gupta
Journal:  BMJ Clin Evid       Date:  2009-04-20

3.  Superovulation alters the expression of endometrial genes critical to tissue remodeling and placentation.

Authors:  Suneeta Senapati; Fan Wang; Teri Ord; Christos Coutifaris; Rui Feng; Monica Mainigi
Journal:  J Assist Reprod Genet       Date:  2018-06-29       Impact factor: 3.412

4.  Ectopic pregnancy in Sokoto, Northern Nigeria.

Authors:  L R Airede; B A Ekele
Journal:  Malawi Med J       Date:  2005-06       Impact factor: 0.875

5.  Bleeding in Early Pregnancy.

Authors:  S Vardhan; T K Bhattacharyya; Sps Kochar; B Sodhi
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 6.  Diagnosis and treatment of ectopic pregnancy.

Authors:  Heather Murray; Hanadi Baakdah; Trevor Bardell; Togas Tulandi
Journal:  CMAJ       Date:  2005-10-11       Impact factor: 8.262

7.  The Values of CA-125, Progesterone, ß-HCG and Estradiol in the Early Prediction of Ectopic Pregnancy.

Authors:  Meena M Abdul-Hussein; Omar F Abdul-Rasheed; Hala Abdul Qadir Al-Moayed
Journal:  Oman Med J       Date:  2012-03

8.  Diagnosis and management of ectopic pregnancy.

Authors:  Vanitha N Sivalingam; W Colin Duncan; Emma Kirk; Lucy A Shephard; Andrew W Horne
Journal:  J Fam Plann Reprod Health Care       Date:  2011-07-04

9.  Photodynamic therapy for gynecological diseases and breast cancer.

Authors:  Natashis Shishkova; Olga Kuznetsova; Temirbolat Berezov
Journal:  Cancer Biol Med       Date:  2012-03       Impact factor: 4.248

10.  Angular-interstitial pregnancy treated with minimally invasive surgery after adjuvant methotrexate medical therapy.

Authors:  Andrea Ciavattini; Isabella Cerè; Dimitrios Tsiroglou; Francesco Maria Caselli; Andrea Luigi Tranquilli
Journal:  JSLS       Date:  2007 Jan-Mar       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.